Hims & Hers shares surge 8% on promising FDA peptide review
Shares of Hims & Hers Health jumped more than 8% to approximately $26 on Thursday after the U.S. Food and Drug Administration announced it would begin a formal review process that could eventually alter the regulatory standing of several wellness peptides used in compounding pharmacies — a development the market interpreted as a meaningful signal […] The post Hims & Hers shares surge 8% on promising FDA peptide review appeared first on Rolling Out.
Black News 
Shares of Hims & Hers Health jumped more than 8% to approximately $26 on Thursday after the U.S. Food and Drug Administration announced it would begin a formal review process that could eventually alter the regulatory standing of several wellness peptides used in compounding pharmacies — a development the market interpreted as a meaningful signal […]
The post Hims & Hers shares surge 8% on promising FDA peptide review appeared first on Rolling Out.
